Neuroblastic Tumor — Trials

Neuroblastic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

619 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 75
Ph III recruiting: 8
Growth YoY: −28%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (80)

clinicaltrialsPublishedShowing 1–50 of 117 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01857934	Therapy for Children With Advanced Stage Neuroblastoma	completed	Phase 2	153	St. Jude Children's Research HospitalOTHER	1	Sep 22, 2026	clinicaltrials
NCT05027386	Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.	completed	Phase 1 / Phase 2	125	Sun Yat-sen UniversityOTHER	1	Sep 10, 2026	clinicaltrials